Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

Share Price is delayed by 15 minutes
Get Live Data
213.80    2.20 (1.04%)
Bid:
213.80
Ask:
214.00
Spread: 0.20 (0.094%)
Market Cap: £4.18b
CTEC Live PriceLast checked at - London Stock Exchange

Intraday ConvaTec Share Chart

Results of AGM

11 May 2017 14:22

RNS Number : 9082E
ConvaTec Group PLC
11 May 2017
 

 

Result of Meeting

 

 

 

CONVATEC GROUP PLC - AGM

11 MAY 2017 - POLL RESULT

 

ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, held its annual general meeting today. The results of the poll held in relation to the resolutions proposed at the meeting are set out below.

 

For (see note 2)

Against (see note 2)

Number of votes Withheld (see note 3)

Total Capital Instructed

Resolution

No of shares

%

No of Shares

%

1

Receive Annual Reports and Accounts

1,673,547,389

99.40

10,098,465

0.60

687,156

86.28%

2

Approve the Directors' Remuneration Report

1,649,328,475

97.94

34,666,528

2.06

338,007

86.29%

3

Approve the Directors' Remuneration Policy

1,674,663,195

99.45

9,331,808

0.55

338,007

86.29%

4

Elect Sir Christopher Gent as a director

1,676,668,959

99.58

7,122,017

0.42

542,034

86.28%

5

Elect Paul Moraviec as a director

1,659,821,604

98.56

24,175,399

1.44

336,007

86.29%

6

Elect Nigel Clerkin as a director

1,659,401,604

98.54

24,595,399

1.46

336,007

86.29%

7

Elect Steve Holliday as a director

1,677,375,498

99.61

6,621,505

0.39

336,007

86.29%

8

Elect Jesper Ovesen as a director

1,671,684,756

99.27

12,312,247

0.73

336,007

86.29%

9

Elect Rick Anderson as a director

1,679,301,346

99.72

4,695,657

0.28

336,007

86.29%

10

Elect Raj Shah as a director

1,646,289,348

98.06

32,613,689

1.94

5,429,973

86.03%

11

Elect Kasim Kutay as a director

1,655,528,107

98.31

28,468,896

1.69

336,007

86.29%

12

Appoint Deloitte LLP as auditors

1,683,082,895

99.95

914,108

0.05

336,007

86.29%

13

Authorise the Directors to agree the auditors' remuneration

1,681,391,151

99.85

2,605,452

0.15

336,407

86.29%

14

Authorise allotment of shares

1,529,102,605

90.93

152,583,558

9.07

2,646,847

86.18%

15

Authorise scrip dividend alternative

1,683,571,466

99.97

425,537

0.03

336,007

86.29%

16

Disapply pre-emption rights*

1,680,232,470

99.76

4,052,383

0.24

48,157

86.31%

17

Disapply pre-emption rights in connection with an acquisition or specified capital investment*

1,505,385,444

89.38

178,899,409

10.62

48,157

86.31%

18

Authorise purchase of own shares*

1,679,583,213

99.82

3,010,097

0.18

1,739,700

86.22%

19

Approve SAYE option scheme

1,680,350,606

99.77

3,932,247

0.23

50,157

86.31%

20

Approve US Employee Share Purchase Plan

1,683,935,777

99.98

347,076

0.02

50,157

86.31%

21

Authorise political donations and political expenditure

1,682,860,783

99.93

1,136,220

0.07

336,007

86.29%

22

Call general meetings on 14 days' notice*

1,662,315,089

98.71

21,681,914

1.29

336,007

86.29%

 

*Special Resolution

 

NOTES:

 

1. All resolutions were passed.

2. Votes "For" and "Against" are expressed as a percentage of votes received.

3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

4. Total number of shares in issue at 6.30pm on 9 May 2017 was 1,951,472,651 shares. XX.XX% of voting capital was instructed.

 

 

 

 

 

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. www.convatecgroup.com

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

Enquiries

 

Analysts and Investors

 

John Crosse, VP Investor Relations, ConvaTec +44 (0)7500 141 435

Kirsty Law, Director Investor Relations, ConvaTec +44 (0)7470 909 582

investorrelations@convatec.com

 

Media

 

Bobby Leach, VP Group Corporate Affairs, ConvaTec +44 (0)7770 842 226

Rebecca Fitchett, Finsbury +44 (0)207 251 3801

# # #

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGOKDDBNBKDDPD
Date   Source Headline
25th Jun 202611:00 amRNSHolding(s) in Company
28th May 202611:00 amRNSHolding(s) in Company
27th May 202611:00 amRNSDirector/PDMR Shareholding
26th May 202611:00 amRNSHolding(s) in Company
21st May 20263:30 pmRNSResults of AGM
21st May 20267:00 amRNSAGM trading update for four months ended 30 April
13th Apr 202612:00 pmRNSProfessor Constantin Coussios steps down
9th Apr 20267:00 amRNSCapital Markets Day
17th Mar 20261:00 pmRNSNotice of AGM
17th Mar 202611:00 amRNSDirector/PDMR Shareholding
12th Mar 20262:30 pmRNSDirector/PDMR Shareholding
10th Mar 20261:00 pmRNSPublication of Annual Report
24th Feb 20267:00 amRNSConvatec FY25 Results
6th Feb 202611:00 amRNSHolding(s) in Company
2nd Jan 202611:00 amRNSTotal Voting Rights
19th Dec 202512:00 pmRNSHolding(s) in Company
19th Dec 202512:00 pmRNSHolding(s) in Company
17th Dec 20253:00 pmRNSHolding(s) in Company
10th Dec 20253:00 pmRNSHolding(s) in Company
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 202512:00 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 202511:00 amRNSTotal Voting Rights
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 202511:00 amRNSHolding(s) in Company
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20255:05 pmRNSHolding(s) in Company
24th Nov 20255:00 pmRNSHolding(s) in Company
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20255:30 pmRNSHolding(s) in Company
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20251:30 pmRNSHolding(s) in Company
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20256:00 pmRNSConvaTec Group
18th Nov 20257:00 amRNSPRICED SECONDARY OFFERING IN CONVATEC GROUP PLC
17th Nov 20254:57 pmRNSPROPOSED SECONDARY OFFERING IN CONVATEC GROUP PLC
14th Nov 20253:00 pmRNSHolding(s) in Company
13th Nov 20257:05 amRNSTransaction in Own Shares
13th Nov 20257:00 amRNSTrading update for 10 months ended 31 October 2025
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:05 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSCEO and CFO appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.